Encompassing theory and field experience, this book covers all the main subject areas in earthquake risk reduction, ranging from geology, seismology, structural and soil dynamics to hazard and risk assessment, risk management and planning, engineering and the architectural design of new structures and equipment. Earthquake Risk Reduction outlines individual national weaknesses that contribute to earthquake risk to people and property; calculates the seismic response of soils and structures, using the structural continuum 'Subsoil - Substructure - Superstructure - Non-structure'; evaluates the effectiveness of given designs and construction procedures for reducing casualties and financial losses; provides guidance on the key issue of choice of structural form; presents earthquake resistant designs methods for the four main structural materials - steel, concrete, reinforced masonry and timber - as well as for services equipment, plant and non-structural architectural components; contains a chapter devoted to problems involved in improving (retrofitting) the existing built environment. Compiled from the author's extensive professional experience in earthquake engineering, this key text provides an excellent treatment of the complex multidisciplinary process of earthquake risk reduction. This book will prove an invaluable reference and guiding tool to practicing civil and structural engineers and architects, researchers and postgraduate students in seismology, local governments and risk management officials.
Earthquake Resistant Design and Risk Reduction, 2nd edition is based upon global research and development work over the last 50 years or more, and follows the author’s series of three books Earthquake Resistant Design, 1st and 2nd editions (1977 and 1987), and Earthquake Risk Reduction (2003). Many advances have been made since the 2003 edition of Earthquake Risk Reduction, and there is every sign that this rate of progress will continue apace in the years to come. Compiled from the author’s wide design and research experience in earthquake engineering and engineering seismology, this key text provides an excellent treatment of the complex multidisciplinary process of earthquake resistant design and risk reduction. New topics include the creation of low-damage structures and the spatial distribution of ground shaking near large fault ruptures. Sections on guidance for developing countries, response of buildings to differential settlement in liquefaction, performance-based and displacement-based design and the architectural aspects of earthquake resistant design are heavily revised. This book: Outlines individual national weaknesses that contribute to earthquake risk to people and property Calculates the seismic response of soils and structures, using the structural continuum “Subsoil – Substructure – Superstructure – Non–structure” Evaluates the effectiveness of given design and construction procedures for reducing casualties and financial losses Provides guidance on the key issue of choice of structural form Presents earthquake resistant design methods for the main four structural materials – steel, concrete, reinforced masonry and timber – as well as for services equipment, plant and non-structural architectural components Contains a chapter devoted to problems involved in improving (retrofitting) the existing built environment This book is an invaluable reference and guiding tool to practising civil and structural engineers and architects, researchers and postgraduate students in earthquake engineering and engineering seismology, local governments and risk management officials.
The Maudsley® Deprescribing Guidelines Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance for all commonly used medications, covering common pitfalls, troubleshooting, supportive strategies, and more. Most formal guidance on psychiatric medication relates to starting or switching medications with minimal guidance on deprescribing medication. In 2023, the World Health Organisation and the United Nations called for patients, as a human right, to be informed of their right to discontinue treatment and to receive support to do so. The Maudsley Deprescribing Guidelines fills a significant gap in guidance for clinicians by providing comprehensive and authoritative information on this important aspect of treatment. This evidence-based handbook provides an overview of principles to be used in deprescribing. This is derived from fundamental scientific principles and the latest research on this topic, combined with emerging insights from clinical practice (including from patient experts). Building on the recognised brand of The Maudsley Prescribing Guidelines, and the prominence of the authors’ work, including in The Lancet Psychiatry on tapering antidepressants (the most read article across all Lancet titles when it was released). The Maudsley Deprescribing Guidelines covers topics such as: Why and when to deprescribe antidepressants, benzodiazepines, gabapentinoids and z-drugs Barriers and enablers to deprescribing including physical dependence, social circumstances, and knowledge about the discontinuation process Distinguishing withdrawal symptoms, such as poor mood, anxiety, insomnia, and a variety of physical symptoms from symptoms of the underlying disorder that medication was intended to treat The difference between physical dependence and addiction/substance use disorder Explanation of why and how to implement hyperbolic tapering in clinical practice Specific guidance on formulations of medication and techniques for making gradual reductions, including using liquid forms of medication, and other approaches Step-by-step guidance for safely stopping all commonly used antidepressants, benzodiazepines, gabapentinoids and z-drugs, including fast, moderate and slow tapering regimens or schedules for each drug, and guidance on how to tailor these to an individual Troubleshooting issues which can arise on stopping these medications, including akathisia, withdrawal symptoms, acute or protracted, and relapse. Written for anyone interested in safe deprescribing of psychiatric medications including psychiatrists, GPs, pharmacists, nurses, medical trainees, and interested members of the public. The Maudsley Deprescribing Guidelines is an essential resource on the subject that provides practical guidance on how to improve patient outcomes in this field of medicine.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.